NCT01895894View on ClinicalTrials.gov

Mycophenolate Mofetil in Pediatric Steroid Dependent Nephrotic Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Nephrotic Syndrome
Interventions
DRUG

Mycophenolate mofetil

Mycophenolate mofetil 20\~30mg/kg/day PO until nephrotic syndrome relapse (max. 1 year)

Trial Locations (1)

110-740

Seoul National University Children's Hospital, Seoul

Sponsors
All Listed Sponsors
collaborator

Chong Kun Dang Pharmaceutical

INDUSTRY

lead

Seoul National University Hospital

OTHER

NCT01895894 - Mycophenolate Mofetil in Pediatric Steroid Dependent Nephrotic Syndrome | Biotech Hunter | Biotech Hunter